
Researchers at LMU have successfully tested a novel medication that can greatly prolong the lives of patients with breast cancer.
A recent joint investigation identified uncommon mutations in the YKT6 gene as the source of a novel neurological illness characterised…
Children diagnosed with type 1 diabetes are at significantly higher risk of a number of…
Scientists at the DZD partner German Institute of Human Nutrition Potsdam-Rehbrucke (DIfE) have now explored…
Alzheimer's disease, the most common type of dementia, currently affects twice as many women as…
Hormone modulating therapy (HMT) used for the treatment of breast cancer was associated with a…
Early exposure to antibiotics might increase long-term vulnerability to asthma. Importantly, the study team discovered…
Sign in to your account
